Literature DB >> 28548676

The Diagnosis and Management of Chronic Migraine in Primary Care.

Werner J Becker1.   

Abstract

BACKGROUND: Chronic migraine is common, affecting approximately 1% of the general population, and causes significant disability.
OBJECTIVE: To summarize optimal involvement of primary care physicians in chronic migraine care, and to provide algorithms to assist them in the diagnosis and management of patients with chronic migraine.
METHODS: An analysis of diagnostic and treatment needs in chronic migraine, based on a synthesis of the medical literature and clinical experience.
RESULTS: Chronic migraine represents the more severe end of the migraine spectrum, usually arises out of previous episodic migraine, and is characterized by headache on 15 days a month or more. Importantly, the headache needs to meet migraine diagnostic criteria on only 8 days a month in order to meet chronic migraine diagnostic criteria. When acute medication overuse is present, a second diagnosis of medication overuse headache should be made. If patients meet criteria for chronic migraine, this excludes a diagnosis of chronic tension-type headache. Acute therapy of chronic migraine is similar to episodic migraine, except that medication overuse is a much greater risk in chronic migraine and must be addressed. All patients should be considered for pharmacological prophylaxis, and the behavioral aspects of therapy should be emphasized. The two prophylactic drugs with the best evidence for efficacy in chronic migraine are topiramate and onabotulinumtoxinA. Given the disability caused by chronic migraine, these should both be available to patients as necessary.
CONCLUSION: Management of chronic migraine is complex, and many patients are relatively refractory to therapy. Specialist referral will often be required and should not be unduly delayed. On the other hand, the primary care physician should be able to make the diagnosis, initiate therapy, and manage some less refractory patients without referral. The timing of referral should depend both on the expertise of the primary care physician in headache management and the patient's response to initial therapy.
© 2017 American Headache Society.

Entities:  

Keywords:  amitriptyline; chronic migraine; diagnosis; onabotulinumtoxinA; topiramate; treatment

Mesh:

Year:  2017        PMID: 28548676     DOI: 10.1111/head.13089

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  9 in total

1.  Levels and determinants of knowledge about chronic migraine diagnosis and management among primary health-care physicians in ministry of health, Jeddah 2019.

Authors:  Mohammed Ahmed Aljunaid; Hussain Hassan Jamal; Anas Ahmed Mubarak; Wedad Bardisi
Journal:  J Family Med Prim Care       Date:  2020-05-31

2.  A Prospective Observational Cohort Study on Pharmacological Habitus, Headache-Related Disability and Psychological Profile in Patients with Chronic Migraine Undergoing OnabotulinumtoxinA Prophylactic Treatment.

Authors:  Marialuisa Gandolfi; Valeria Donisi; Fabio Marchioretto; Simone Battista; Nicola Smania; Lidia Del Piccolo
Journal:  Toxins (Basel)       Date:  2019-08-29       Impact factor: 4.546

3.  Prevalence and factors associated with the use of primary headache diagnostic criteria by chiropractors.

Authors:  Craig Moore; Andrew Leaver; David Sibbritt; Jon Adams
Journal:  Chiropr Man Therap       Date:  2019-08-06

4.  Factors Affecting Preventive Treatment Outcomes for Patients With Newly Diagnosed Chronic Migraine and Their Compliance With Treatment Recommendations in Chongqing Province, China: An Open-Label Prospective Study With Retrospective Baseline.

Authors:  Dongli Yuan; Yixin Zhang; Qin Li; Yuhua Lv; Xuelian Li; Yichuan Yu; Wangwen Li; Ge Tan
Journal:  Front Neurol       Date:  2020-04-09       Impact factor: 4.003

5.  P2Y12 receptor mediates microglial activation via RhoA/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine.

Authors:  Feng Jing; Yixin Zhang; Ting Long; Wei He; Guangcheng Qin; Dunke Zhang; Lixue Chen; Jiying Zhou
Journal:  J Neuroinflammation       Date:  2019-11-13       Impact factor: 8.322

6.  Analysis of treatment cost and persistence among migraineurs: A two-year retrospective cohort study in Pakistan.

Authors:  Kamran Khan; Mudassar Iqbal Arain; Muhammad Arif Asghar; Ahad Abdul Rehman; Muhammad Ali Ghoto; Abdullah Dayo; Muhammad Suleman Imtiaz; Mohsin Hamied Rana; Muhammad Asif Asghar
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

Review 7.  Practical Insights on the Identification and Management of Patients with Chronic Migraine.

Authors:  Andrew Blumenfeld; Aud Nome Dueland; Stefan Evers; Bronwyn Jenkins; Paolo Martelletti; Katherine Sommer
Journal:  Pain Ther       Date:  2022-04-20

8.  Validation of an algorithm for automated classification of migraine and tension-type headache attacks in an electronic headache diary.

Authors:  Aaron Roesch; Markus A Dahlem; Lars Neeb; Tobias Kurth
Journal:  J Headache Pain       Date:  2020-06-12       Impact factor: 7.277

9.  Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation.

Authors:  Feng Jing; Qian Zou; Yangyang Wang; Zhiyou Cai; Yong Tang
Journal:  J Headache Pain       Date:  2021-07-29       Impact factor: 7.277

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.